Literature DB >> 25607739

A multicentered prospective analysis of diagnosis, risk factors, and outcomes associated with pediatric ventilator-associated pneumonia.

Sameer Gupta1, Brian M Boville, Rachel Blanton, Gloria Lukasiewicz, Jeni Wincek, Chunhong Bai, Michael L Forbes.   

Abstract

OBJECTIVE: To assess risk factors and outcomes associated with pediatric ventilator-associated pneumonia.
DESIGN: Multicentered prospective observational cohort.
SETTING: Children's hospitals in the United States. PATIENTS: Mechanically ventilated patients less than 18 years old.
MEASUREMENTS AND MAIN RESULTS: Prospective evaluation of the prevalence, risk factors, and outcomes of pediatric ventilator-associated pneumonia along with evaluation of diagnostic criterion for pediatric ventilator-associated pneumonia. The prevalence of pediatric ventilator-associated pneumonia was 5.2% (n = 2,082), for a rate of 7.1/1,000 ventilator days. Patients with ventilator-associated pneumonia had a longer unadjusted ICU length of stay (p < 0.0001) and increased length of mechanical ventilation by more than 11 days (p < 0.0001). After adjustment for patient factors, ICU length of stay (p = 0.03) and mechanical ventilation days (p = 0.001) remained significant. Patients with ventilator-associated pneumonia were almost three times more likely to die (p = 0.007). Independent risk factors for ventilator-associated pneumonia were reintubation and part-time ventilation.
CONCLUSIONS: Pediatric ventilator-associated pneumonia is common in mechanically ventilated pediatric patients. These patients have longer length of stay, longer duration of mechanical ventilation, and increased risk for mortality.

Entities:  

Mesh:

Year:  2015        PMID: 25607739     DOI: 10.1097/PCC.0000000000000338

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  12 in total

1.  Nutritional Status Based on Body Mass Index Is Associated With Morbidity and Mortality in Mechanically Ventilated Critically Ill Children in the PICU.

Authors:  Lori J Bechard; Christopher Duggan; Riva Touger-Decker; J Scott Parrott; Pamela Rothpletz-Puglia; Laura Byham-Gray; Daren Heyland; Nilesh M Mehta
Journal:  Crit Care Med       Date:  2016-08       Impact factor: 7.598

2.  Application of the New Centers for Disease Control and Prevention Surveillance Criteria for Ventilator-Associated Events to a Cohort of PICU Patients Identifies Different Patients Compared With the Previous Definition and Physician Diagnosis.

Authors:  Katherine M Ziegler; Jonathan D Haywood; Marci K Sontag; Peter M Mourani
Journal:  Crit Care Med       Date:  2019-07       Impact factor: 7.598

3.  Ventilator-Associated Pneumonia in Pediatric Traumatic Brain Injury.

Authors:  Mitchell Hamele; Chris Stockmann; Meghan Cirulis; Jay Riva-Cambrin; Ryan Metzger; Tellen D Bennett; Susan L Bratton
Journal:  J Neurotrauma       Date:  2015-10-02       Impact factor: 5.269

4.  New Biomarkers to Diagnose Ventilator Associated Pneumonia: Pentraxin 3 and Surfactant Protein D.

Authors:  Nazan Ulgen Tekerek; Basak Nur Akyildiz; Baris Derya Ercal; Sabahattin Muhtaroglu
Journal:  Indian J Pediatr       Date:  2018-02-02       Impact factor: 1.967

5.  Enteral Nutrition and Acid-Suppressive Therapy in the PICU: Impact on the Risk of Ventilator-Associated Pneumonia.

Authors:  Ben D Albert; David Zurakowski; Lori J Bechard; Gregory P Priebe; Christopher P Duggan; Daren K Heyland; Nilesh M Mehta
Journal:  Pediatr Crit Care Med       Date:  2016-10       Impact factor: 3.624

6.  Comparison of the New Adult Ventilator-Associated Event Criteria to the Centers for Disease Control and Prevention Pediatric Ventilator-Associated Pneumonia Definition (PNU2) in a Population of Pediatric Traumatic Brain Injury Patients.

Authors:  Meghan M Cirulis; Mitchell T Hamele; Chris R Stockmann; Tellen D Bennett; Susan L Bratton
Journal:  Pediatr Crit Care Med       Date:  2016-02       Impact factor: 3.624

7.  Duration of Postoperative Mechanical Ventilation as a Quality Metric for Pediatric Cardiac Surgical Programs.

Authors:  Michael Gaies; David K Werho; Wenying Zhang; Janet E Donohue; Sarah Tabbutt; Nancy S Ghanayem; Mark A Scheurer; John M Costello; J William Gaynor; Sara K Pasquali; Justin B Dimick; Mousumi Banerjee; Steven M Schwartz
Journal:  Ann Thorac Surg       Date:  2017-10-05       Impact factor: 4.330

8.  Active surveillance of ventilator-associated pneumonia in the intensive care unit and establishment of the risk grading system and effect evaluation.

Authors:  Weiping Liu; Yueying Jiao; Huimin Xing; Yunting Hai; Haoxue Li; Kai Zhang; Yuping Zhao; Yongfang Yang; Binbin Xu; Haibo Bai; Huan Bao; Shuai Zhang; Tianhui Guo
Journal:  Ann Transl Med       Date:  2019-11

9.  Diagnosis and Treatment of Ventilator-Associated Infection: Review of the Critical Illness Stress-Induced Immune Suppression Prevention Trial Data.

Authors:  Douglas F Willson; Angela Webster; Sabrina Heidemann; Kathleen L Meert
Journal:  Pediatr Crit Care Med       Date:  2016-04       Impact factor: 3.624

10.  In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.

Authors:  Aytekin Cikman; Baris Gulhan; Merve Aydin; Mehmet Resat Ceylan; Mehmet Parlak; Faruk Karakecili; Alper Karagoz
Journal:  Int J Med Sci       Date:  2015-08-14       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.